In atherosclerosis, berberine treatment inhibits inflammation in mouse macrophages (J774A.1) by inducing autophagy through AMPK/mTOR pathway (43) and uncoupling protein 2 in mice (44). The gene discussed is MTOR; the disease is atherosclerosis.